| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5811971 | Medical Hypotheses | 2013 | 4 Pages |
Abstract
If the observed increase of glycine consumption in rapidly proliferating cancer cells has its basis in the need for heme biosynthesis, then mitochondrial serine hydroxymethyltransferase should be considered as a key target for the development of new chemotherapic agents.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Developmental Biology
Authors
Martino L. di Salvo, Roberto Contestabile, Alessandro Paiardini, Bruno Maras,